NCT06721429 The Effect of Dual-task Training on Balance, Exercise Capacity, Cognitive Status, and Quality of Life
| NCT ID | NCT06721429 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bartın Unıversity |
| Condition | Diabetes Mellitus, Type 2 |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2024-12-25 |
| Primary Completion | 2025-02-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2024-12-25 with a primary completion date of 2025-02-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to investigate the effects of dual-task training on balance, exercise capacity, cognitive function, and quality of life in individuals with Type 2 Diabetes Mellitus (DM). As a result of this study, it is hoped that dual-task training will be an alternative to single-task training in the rehabilitation of individuals with Type 2 DM, with the goal of preventing falls and supporting a more active lifestyle. Additionally, it is intended to include dual-task training in preventive physiotherapy approaches. The main questions the study aims to answer are as follows: Is dual-task training, conducted concurrently with exercise training, more effective in improving balance when compared to exercise training alone and the control group? Is dual-task training, conducted concurrently with exercise training, more effective in improving exercise capacity, cognitive function, and quality of life when compared to exercise training alone and the control group? The researchers will compare the effects of dual-task training in individuals with Type 2 diabetes by comparing the participants in the single-task exercise training group and the control group. Participants will be randomized into the dual-task exercise training group, the single-task exercise training group, and the control group. Individuals in the training group will undergo exercise training three days a week for 8 weeks.
Eligibility Criteria
Inclusion Criteria: * Being followed up with a diagnosis of Type 2 Diabetes Mellitus for at least 6 months (fasting plasma glucose of 7.0 mmol/L or higher) * Not having participated in any structured exercise program for at least 6 months prior. * Being willing to volunteer for the study Exclusion Criteria: * Nephropathy * Retinopathy * Having dementia or Alzheimer's disease * Using a walking aid * Having ulceration * Using balance-curing drugs * Surviving myocardial infarction at least 6 months ago * Stable or unstable angina pectoris * Left ventricular ejection fraction below 40% * Peripheral arterial diseases * Resting blood pressure above 160/100 mmHg * Body mass index above 35 kg/m2 * Having a history of deep vein thrombosis, pulmonary embolism or stroke in the past
Contact & Investigator
gizem mermerkaya
PRINCIPAL INVESTIGATOR
Bartın Unıversity
Frequently Asked Questions
Who can join the NCT06721429 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Diabetes Mellitus, Type 2. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06721429 currently recruiting?
Yes, NCT06721429 is actively recruiting participants. Contact the research team at gizmyagiz@gmail.com for enrollment information.
Where is the NCT06721429 trial being conducted?
This trial is being conducted at Bartın, Turkey (Türkiye).
Who is sponsoring the NCT06721429 clinical trial?
NCT06721429 is sponsored by Bartın Unıversity. The principal investigator is gizem mermerkaya at Bartın Unıversity. The trial plans to enroll 36 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.